🔗 Visit the ClinicalTrials.gov page for NCT02488811
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Combination cancer immunotherapies tailored to the tumour microenvironment. | Nat Rev Clin Oncol | 2015 | 1.54 |
| 2 | Original insights on thrombospondin-1-related antireceptor strategies in cancer. | Front Pharmacol | 2015 | 0.82 |
| 3 | Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation. | Cell Death Differ | 2016 | 0.82 |
| 4 | Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47. | Sci Rep | 2016 | 0.75 |